Ekos wins $2.7 million NIH grant
This article was originally published in The Gray Sheet
Executive Summary
Firm receives $2.7 million grant from the National Institutes of Health for development of its ultrasonic accelerated drug-delivery technology to treat intracerebral hemorrhagic stroke. The Bothell, Wash., company's EkoSonic endovascular system is already FDA-cleared for controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature